Jim Simons’s Immune Design Corp. IMDZ Stock Holding History

Jim Simons’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,031,905	Closed	-$6.04M	–	3903
2019 Q1	$6.04M	Buy	1,031,905 +507,100	+97%	+$1.73M	0.01%	1687
2018 Q4	$682K	Buy	524,805 +377,591	+256%	+$656K	﹤0.01%	2742
2018 Q3	$508K	Buy	+147,214	New	+$553K	﹤0.01%	2842
2017 Q4	–	Sell	-123,591	Closed	-$1.28M	–	3667
2017 Q3	$1.28M	Sell	123,591 -16,209	-12%	-$160K	﹤0.01%	2480
2017 Q2	$1.36M	Buy	139,800 +28,060	+25%	+$197K	﹤0.01%	2451
2017 Q1	$760K	Buy	111,740 +70,351	+170%	+$407K	﹤0.01%	2637
2016 Q4	$228K	Sell	41,389 -75,111	-64%	-$531K	﹤0.01%	2969
2016 Q3	$883K	Buy	+116,500	New	+$852K	﹤0.01%	2627

Jim Simons's IMDZ Position: Q2 2019 in Review

Jim Simons sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 1,031,905 shares — an estimated $6.04M sold.

Jim Simons first reported a position in IMDZ in Q3 2016 and held it in 8 quarters. The position peaked at $6.04M in Q1 2019. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.

Jim Simons reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
Jim Simons sold 1,031,905 Immune Design Corp. shares in Q2 2019, an estimated $6.04M.
Jim Simons first reported a position in Immune Design Corp. in Q3 2016 and held it in 8 quarters.
Jim Simons's Immune Design Corp. position peaked at $6.04M in Q1 2019.
0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.

Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.